Novartis announced recently that it has restarted radioligand therapy (RLT) production at two different sites. Basel, Switzerland-based Novartis on June 30 said that it restarted production in “early June” at its Ivrea, Italy, and Millburn, New Jersey, sites, according to a news release. The company had halted production in May due to what it cited…